<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-05T19:23:39Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/45078" metadataPrefix="didl">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/45078</identifier><datestamp>2021-06-24T07:17:13Z</datestamp><setSpec>com_10324_44585</setSpec><setSpec>com_10324_954</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_44586</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
<d:DIDLInfo>
<dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2021-01-19T13:31:14Z</dcterms:created>
</d:DIDLInfo>
<d:Item id="hdl_10324_45078">
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10324/45078</dii:Identifier>
</d:Statement>
</d:Descriptor>
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>RhoA–ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells</dc:title>
<dc:creator>Ordóñez Morán, Paloma</dc:creator>
<dc:creator>Larriba, María Jesús</dc:creator>
<dc:creator>García Palmer, Héctor</dc:creator>
<dc:creator>Valero, Ruth Ana</dc:creator>
<dc:creator>Barbáchano Becerril, Antonio</dc:creator>
<dc:creator>Duñach Masjuan, Mireia</dc:creator>
<dc:creator>García de Herreros, Antonio</dc:creator>
<dc:creator>Villalobos Jorge, Carlos</dc:creator>
<dc:creator>Berciano, María Teresa</dc:creator>
<dc:creator>Lafarga Coscojuela, Miguel Ángel</dc:creator>
<dc:creator>Muñoz Terol, Alberto</dc:creator>
<dc:description>Producción Científica</dc:description>
<dc:description>The active vitamin D metabolite 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) inhibits proliferation and promotes differentiation of colon cancer cells through the activation of vitamin D receptor (VDR), a transcription factor of the nuclear receptor superfamily. Additionally, 1,25(OH)2D3 has several nongenomic effects of uncertain relevance. We show that 1,25(OH)2D3 induces a transcription-independent Ca2+ influx and activation of RhoA–Rho-associated coiled kinase (ROCK). This requires VDR and is followed by activation of the p38 mitogen-activated protein kinase (p38MAPK) and mitogen- and stress-activated kinase 1 (MSK1). As shown by the use of chemical inhibitors, dominant-negative mutants and small interfering RNA, RhoA–ROCK, and p38MAPK-MSK1 activation is necessary for the induction of CDH1/E-cadherin, CYP24, and other genes and of an adhesive phenotype by 1,25(OH)2D3. RhoA–ROCK and MSK1 are also required for the inhibition of Wnt–β-catenin pathway and cell proliferation. Thus, the action of 1,25(OH)2D3 on colon carcinoma cells depends on the dual action of VDR as a transcription factor and a nongenomic activator of RhoA–ROCK and p38MAPK-MSK1.</dc:description>
<dc:date>2021-01-19T13:31:14Z</dc:date>
<dc:date>2021-01-19T13:31:14Z</dc:date>
<dc:date>2008</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>Journal of Cell Biology, 2008, vol. 183, n. 4. p. 697-710</dc:identifier>
<dc:identifier>1540-8140</dc:identifier>
<dc:identifier>http://uvadoc.uva.es/handle/10324/45078</dc:identifier>
<dc:identifier>10.1083/jcb.200803020</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>https://rupress.org/jcb/article/183/4/697/45660/RhoA-ROCK-and-p38MAPK-MSK1-mediate-vitamin-D</dc:relation>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/</dc:rights>
<dc:rights>© 2008 Rockefeller University Press</dc:rights>
<dc:rights>Attribution-NonCommercial-NoDerivs 3.0 Unported</dc:rights>
<dc:publisher>Rockefeller University Press</dc:publisher>
</oai_dc:dc>
</d:Statement>
</d:Descriptor>
<d:Component id="10324_45078_1">
<d:Resource ref="https://uvadoc.uva.es/bitstream/10324/45078/1/RhoA-ROCK.pdf" mimeType="application/pdf"/>
</d:Component>
</d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>